314 related articles for article (PubMed ID: 25031732)
1. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
[TBL] [Abstract][Full Text] [Related]
2. Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.
Hasan R; Sharma R; Saraya A; Chattopadhyay TK; DattaGupta S; Walfish PG; Chauhan SS; Ralhan R
BMC Cancer; 2014 Jan; 14():2. PubMed ID: 24383423
[TBL] [Abstract][Full Text] [Related]
3. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis.
Hijiya N; Shibata T; Daa T; Hamanaka R; Uchida T; Matsuura K; Tsukamoto Y; Nakada C; Iha H; Inomata M; Moriyama M
Pathol Int; 2017 Feb; 67(2):83-90. PubMed ID: 27976824
[TBL] [Abstract][Full Text] [Related]
6. High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.
Hao CL; Li Y; Yang HX; Luo RZ; Zhang Y; Zhang MF; Cheng YF; Wang X
Int J Clin Exp Pathol; 2014; 7(7):4213-21. PubMed ID: 25120801
[TBL] [Abstract][Full Text] [Related]
7. The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.
Zhang JY; Bai CY; Bai YQ; Zhang JY; Wu ZY; Wang SH; Xu XE; Wu JY; Zhu Y; Rui Y; Li EM; Xu LY
Hum Pathol; 2014 Oct; 45(10):2014-22. PubMed ID: 25090917
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
9. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.
Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ
Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
[TBL] [Abstract][Full Text] [Related]
12. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
15. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
16. Increased MMP-21 expression in esophageal squamous cell carcinoma is associated with progression and prognosis.
Zhao Z; Yan L; Li S; Sun H; Zhou Y; Li X
Med Oncol; 2014 Aug; 31(8):91. PubMed ID: 25015395
[TBL] [Abstract][Full Text] [Related]
17. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
18. NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma.
Chen GQ; Tian H; Yue WM; Li L; Li SH; Qi L; Gao C; Si LB; Lu M
Med Oncol; 2014 Dec; 31(12):376. PubMed ID: 25416054
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
